Correlation Between Replimune and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Replimune and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Replimune and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Recursion Pharmaceuticals.
Diversification Opportunities for Replimune and Recursion Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Replimune and Recursion is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Replimune i.e., Replimune and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Replimune and Recursion Pharmaceuticals
Given the investment horizon of 90 days Replimune Group is expected to generate 0.95 times more return on investment than Recursion Pharmaceuticals. However, Replimune Group is 1.05 times less risky than Recursion Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 1,113 in Replimune Group on September 26, 2024 and sell it today you would earn a total of 137.00 from holding Replimune Group or generate 12.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Replimune Group |
| Recursion Pharmaceuticals |
Replimune and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Recursion Pharmaceuticals
The main advantage of trading using opposite Replimune and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Replimune vs. Fate Therapeutics | Replimune vs. Caribou Biosciences | Replimune vs. Karyopharm Therapeutics | Replimune vs. Hookipa Pharma |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |